(1) | ||
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | (1) | Proposed maximum offering price per unit | Maximum aggregate offering price | Fee Rate | Amount of Registration Fee | |||||||||||||||||||||||||||
| (2) | $ | (4) | $ | $ | $ | ||||||||||||||||||||||||||||||
| (3) | $ | (5) | $ | $ | $ | ||||||||||||||||||||||||||||||
Total Offering Amounts | 7,661,479 | $ | $ | ||||||||||||||||||||||||||||||||
Total Fees Offset | |||||||||||||||||||||||||||||||||||
Net Fee Due | $ | ||||||||||||||||||||||||||||||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of Class A common stock which become issuable under the above-named plans by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of the Registrant’s outstanding shares of Class A common stock. | ||||
| (2) | Reflects an annual increase on January 1, 2026 to the number of shares of the Registrant’s Class A common stock reserved for issuance under the 10x Genomics, Inc. 2019 Omnibus Incentive Plan (the “Omnibus Incentive Plan”), which annual increase is provided for in the Omnibus Incentive Plan. | ||||
| (3) | Reflects an annual increase on January 1, 2026 to the number of shares of the Registrant’s Class A common stock reserved for issuance under the 10x Genomics, Inc. 2019 Employee Stock Purchase Plan (the “ESPP”), which annual increase is provided for in the ESPP. | ||||
| (4) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and (h) under the Securities Act on the basis of $18.21 per share, which represents the average of the high and low prices of the Registrant’s Class A common stock as reported on the Nasdaq Global Select Market on February 12, 2026. | ||||
| (5) | |||||